Intelligent Medicine Acquisition Corp. Warrant
IQMDW
IQMDW was delisted on the 26th of April, 2023.
49 hedge funds and large institutions have $1.54M invested in Intelligent Medicine Acquisition Corp. Warrant in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 3 closing their positions.
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
9% more funds holding
Funds holding: 45 → 49 (+4)
46% less capital invested
Capital invested by funds: $2.84M → $1.54M (-$1.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
YCM
Yakira Capital Management
Westport,
Connecticut
|
+$2.15K |
| 2 |
SG
StoneX Group
New York
|
+$1.25K |
| 3 |
CS
Clear Street
New York
|
+$996 |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$899 |
| 5 |
BCL
Bracebridge Capital LLC
Boston,
Massachusetts
|
+$538 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CF
Cantor Fitzgerald
New York
|
-$44.5K |
| 2 |
Barclays
London,
United Kingdom
|
-$4.15K |
| 3 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.34K |
| 4 |
Goldman Sachs
New York
|
-$696 |
| 5 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$180 |
IQMDW Hedge Fund Activity: Q1 2023 in Review
49 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Intelligent Medicine Acquisition Corp. Warrant (IQMDW) for Q1 2023, worth a combined $1.54M — down 46% from $2.84M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new IQMDW positions and 3 closed out — a net gain of 4 holders — while 7 added to existing stakes and 3 trimmed.
The largest buyer was Yakira Capital Management, opening a new position worth an estimated $2.15K. The largest seller was Cantor Fitzgerald, cutting an estimated $44.5K.
- 49 institutional investors held Intelligent Medicine Acquisition Corp. Warrant (IQMDW) as of Q1 2023, up from 45 in Q4 2022.
- Funds reported $1.54M of Intelligent Medicine Acquisition Corp. Warrant stock for Q1 2023, down 46% quarter-over-quarter.
- 7 funds opened new Intelligent Medicine Acquisition Corp. Warrant positions in Q1 2023 and 3 closed out, a net change of +4 holders.
- The largest Intelligent Medicine Acquisition Corp. Warrant buyer in Q1 2023 was Yakira Capital Management, an estimated $2.15K added.
- The largest Intelligent Medicine Acquisition Corp. Warrant seller in Q1 2023 was Cantor Fitzgerald, an estimated $44.5K sold.
Based on aggregated 13F filings for Q1 2023.